Prevention Public Health Fund: Viral Hepatitis Prevention

 

Program activities under this funding will allow for CDC to partner with multiple organizations to benefit individuals by substantially reducing viral hepatitis transmission, identifing those that are chronically infected and linking infected individuals with treatment if appropriate. Specifically, the program activities may include but are not limited to:
1.Increasing the proportion of persons living with HCV and HBV who are aware of their infection and referred for prevention and clinical care services.
2.Expanding and improving efforts to develop and disseminate viral hepatitis training and educational materials targeting the public and private sector health care professionals to build capacity to assess, test and medically manage populations at risk for chronic HCV and HBV infection.
3.Supporting state and local health departments and other organizations in linking HCV infected persons to community health centers, clinics serving injection drug users, and other health organizations seeing individuals potentially infected with chronic viral hepatitis.
4.Additional support will be provided for program monitoring, evaluation, capacity building, and technical assistance.

Deleted 04/02/2020 (Archived.) 93.736 Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention Cooperative Agreements Not Applicable. Sections 301(a) and 317N of the Public Health Service Act (42 U.S.C. Section 241(a) and 247b-15) as amended; and Prevention and Public Health Fund (PPHF). Applicants include State or local governments or their Bona Fide Agents, public and private nonprofit organizations, for profit organizations, small, minority, women-owned businesses, universities, colleges, research institutions, hospitals, community-based organizations, faith based organizations, Federally recognized Indian tribal governments, Indian tribes, and Indian tribal organizations. Additional guidance may be provided in individual program announcement. The individual will benefit from the objectives of this program. No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles. Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIMS) staff. For this, or further assistance, contact PGO-TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application. Contact the headquarters or regional office, as appropriate, for application deadlines. From 120 to 180 days. Not Applicable. Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under the Patient Protection and Affordable Care Act. Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by Division of Viral Hepatitis (DVH), NCHHSTP. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicant will be notified that the application did not meet submission requirements.

CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application and Submission information, subsection “Evaluation Criteria” within the individual funding opportunity announcement. Funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and its manifestations. Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HBV and HCV, preventing and delaying the progress of chronic infection, as well as education and training of the general public and health care providers. Recipients may not use funds for clinical care. Recipients may not generally use funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award in another party or provider who is eligible. Not Applicable. Not Applicable. Financial records, supporting documents, statistical records, and all other reports pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42. This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements. Project period is for 1 year with 12-month budget period. See the following for information on how assistance is awarded/released: Assistance is awarded through Notice of Grant Awards to funded applicants. None. Viral Hepatitis Program Contact: Jeffrey L. Efird, MPA, Deputy Director, Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, Mailstop G-37, Atlanta, Georgia, 30333. Email: jle1@cdc.gov

Grants Management Contact: Carla Harper, Grants Management Officer, Department of Health and Human Services, CDC Procurement and Grants Office, 2920 Brandywine Road, MS E-15, Atlanta, GA 30341, Telephone 770-488-2439, Email: CHarper@cdc.gov. Elizabeth Wolfe 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333 Email: eow1@cdc.gov Phone: (404) 639-8531 http://www.Grants.gov 09-2950-2-0-121 - Direct Category A funding:Viral Hepatitis. (Cooperative Agreements) FY 14 $0; FY 15 est $0; and FY 16 est $0 - This project has been continued using 93.270. Awards will range from approximately $30,000 to $500,000 with an average of $150,000. Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm. Fiscal Year 2014: No Current Data Available Fiscal Year 2015: No Current Data Available Fiscal Year 2016: No Current Data Available